Pregnancy loss and thrombophilia: the elusive link

@article{Bennett2012PregnancyLA,
  title={Pregnancy loss and thrombophilia: the elusive link},
  author={Sarah A. Bennett and Catherine N Bagot and Roopen Arya},
  journal={British Journal of Haematology},
  year={2012},
  volume={157}
}
Recurrent pregnancy loss (RPL) affects 1% pregnancies and is multi‐factorial in origin. The role of the acquired thrombophilia antiphospholipid syndrome (APS) as a common and potentially treatable cause of RPL is well established but this is less so for inherited thrombophilia. In obstetric APS the combination of aspirin and heparin has improved outcomes. By analogy, the use of low molecular weight heparin (LMWH) has become commonplace in women with inherited thrombophilia and also those with… Expand
Inherited thrombophilia and anticoagulant therapy for women with reproductive failure
TLDR
A lack of studies revealing appropriate thrombophilia markers and its cutoff values for RF specifically and the role of anticoagulants in pregnancy outcomes is focused on. Expand
Therapeutic Implications of Inherited Thrombophilia in Pregnancy
TLDR
The impact of each inherited prothrombotic factor on cardiovascular and pregnancy outcomes and the role of anticoagulation treatment for women diagnosed with inherited thrombophilia are summarized. Expand
Recurrent pregnancy loss and thrombophilia in women with PCOS.
TLDR
This study attempted to shed light on two medically challenging areas in obstetrics and gynecologydRPL and PCOS, both of which are still uncertain, and any association between hereditary thrombophilias and RPL has not been supported by two prospective cohort studies. Expand
[Hereditary thrombophilias and placental-mediated pregnancy complications in the II./III. trimester].
TLDR
Large, well-designed multicenter studies are needed to elucidate the role of hereditary thrombophilias in cases of PmC and to confirm the benefit of LWH for subsequent pregnancy outcomes. Expand
Inherited Thrombophilia and Pregnancy Complications: Should We Test?
TLDR
In summary, inherited thrombophilia testing is not required outside a clinical trial for women with recurrent pregnancy losses or late pregnancy complications, and the presence of thromBophilia markers does not generally indicate additional therapy during pregnancy, even if a heritable throm bophilic defect is found. Expand
Inherited Thrombophilia and Recurrent Pregnancy Loss
TLDR
The frequency of protein C deficiency and the frequency of two common thrombophilic mutations (Factor V Leiden and Prothrombin G20210A), were not significantly different between patients with recurrent miscarriage and healthy women. Expand
The Putative Role of Factor V Leiden and Prothrombin Mutations in Pregnancy Complications
TLDR
This review study sought to describe the effects of FVL and PT mutations on pregnancy complications and suggested the benefits of screening patients for thrombophilic polymorphisms in identification of women with higher risk of developing thromboembolic events and other related pregnancy complications. Expand
Role of low dose ecosprin and heparin in achieving live births in pregnancy with thrombophilia
TLDR
Thrombophilia is a disorder of haemostatic system that results in increased tendency of thrombus formation in both venous and arterial vascular system that can cause fetal loss, placental abruption, intrauterine growth restriction and severe preeclampsia. Expand
Role of Low Molecular Weight Heparin in the Management of Unexplained Recurrent Pregnancy Loss: A Review of Literature
TLDR
More studies, preferably large multicenter randomized controlled trials, need to be conducted on the use of LMWH to establish a consensus guideline on the treatment of URPL, and many studies show improved live birth rates in women treated with LMWH compared to the control, while some studies show no improvement. Expand
Molecular thrombophilic profile in Mexican patients with idiopathic recurrent pregnancy loss.
TLDR
An association between the ACE I/D polymorphism and IRPL risk in a Mexican population is supported and is supported by the results of this study. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 142 REFERENCES
Acquired and inherited thrombophilia disorders in pregnancy.
TLDR
The most up-to-date knowledge of prevalence, pathogenesis, and diagnosis of acquired and inherited thrombophilias and their relationship and association with pregnancy complications is reviewed. Expand
Do thrombophilias cause placenta-mediated pregnancy complications?
TLDR
It is suggested that causality is not yet proven and that the data to support management with anticoagulant prophylaxis in thrombophilic pregnancies is too immature to consider this an established intervention. Expand
Practice bulletin no. 124: inherited thrombophilias in pregnancy.
TLDR
This document is to review common thrombophilias and their association with maternal venous thromboembolism risk and adverse pregnancy outcomes, indications for screening to detect these conditions, and management options in pregnancy. Expand
Thrombophilia: implications for pregnancy outcome.
TLDR
Screening for, and finding a, thrombophilic disease in patients with problems such as recurrent miscarriage, intrauterine death, intrautine growth restriction and pre-eclampsia, may reflect an increased risk of venous thromboembolism (VTE). Expand
Thrombophilic dimension of recurrent fetal loss in Indian patients
  • S. Vora, S. Shetty, K. Ghosh
  • Medicine
  • Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
  • 2008
TLDR
Thrombophilia is an important contributing factor for both early and late pregnancy losses; approximately two-thirds of cases of unexplained fetal losses could be explained by acquired or heritable throm bophilia or both, which is in line with other western studies. Expand
Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population.
TLDR
APA other than CL, PS and LAC may be associated with RPL, and whether other APA should be considered as a basis for treatment in women with R PL is evaluated. Expand
Familial thrombophilia--the scientific rationale for thrombophylaxis in recurrent pregnancy loss?
TLDR
Uncertainties regarding the aetiology and these disorders is often fatal in the neonatal period, agreement today in regard to genetic, endocrine, uterine and autoimmune factors has changed dramatically with the autoimmune factors being associated with repeat fetal loss. Expand
Outcome of pregnancy in women with hereditary thrombophilia
  • O. Ogueh, M. Chen, G. Spurll, A. Benjamin
  • Medicine
  • International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 2001
TLDR
Pregnancy complications in cases of hereditary thrombophilia may be related to placental abnormalities, and heparin therapy is likely to be useful in preventing miscarriage in cases. Expand
Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis.
TLDR
Carriers of FVL or prothrombin gene mutations have double the risk of experiencing 2 or more miscarriages compared with women without thrombophilias, and it is recommend testing for these mutations in women with RPL. Expand
Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia
TLDR
A benefit was found in patients with a poor prognosis for a live birth (five or more miscarriages), where the live birth rate was increased from 18.2% to 61.6% and the benefit was not statistically significant, probably due to the small number of patients. Expand
...
1
2
3
4
5
...